Co-Director, NICU/PICU Research Group

Phone: 510-428-3276

CHORI Staff Directory
CHORI Intranet



Dr. Durand’s research focus has been multi-center clinical trials, particularly on newborns with severe respiratory distress.   For the last 20 years he has been the director or co-director of the Children’s Hospital Oakland NICU/PICU research group, and the director of clinical research in the Alta Bates Summit NICU.  Over the last 10 years, he has been a principal- or co-investigator in collaborative trials aimed at decreasing the incidence of bronchopulmonary dysplasia, including trials of high frequency ventilation, inhaled nitric oxide, and late surfactant administration.  He has also participated in trials of cerebral cooling for the prevention of the sequelae of asphyxia in term infants, and investigations of the relationship between maternal vitamin D and neonatal bone mineralization.  He has been a long-standing member of the committee which directs the California Perinatal Quality Care Collaborative, the state-wide neonatal quality improvement program.  He is a founding member of the Children’s Hospitals’ Neonatal Consortium, a collaborative group of 25 US Children’s Hospital NICUs which is collecting data to direct NICU quality improvement and clinical trial priorities.  He is currently funded by the NIH as a co-investigator on a multi-center trial of late surfactant administration for ELBW infants, and by the Department of the Army as the principal investigator of a study exploring the role of clinical decision support in fluid and nutrition management of NICU and PICU patients.  





Revised: Monday, January 23, 2012 3:03 PM


© 2005 Children's Hospital Oakland Research Institute
5700 Martin Luther King Jr Way • Oakland, California 94609
Phone 510-450-7600 • Fax 510-450-7910
Site MapDisclaimer